Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Liquan Jin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-9094-624X; OpenAlex author ID A5114050342. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2023: 2 papers · 2024: 1 paper · 2025: none · 2026: 4 papers

Papers 7

  1. Vorinostat Potentiates Chemoimmunotherapy in Immune-Enriched Pancreatic Cancer. Co-author DOI 10.1002/advs.202521844↗
  2. Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer. First author DOI 10.1016/j.ccell.2026.05.012↗
  3. Metabolic characterization of the tumor microenvironment orchestrates therapeutic strategies and clinical outcomes in pancreatic cancer. Co-author DOI 10.1038/s41467-026-73702-z↗
  4. Impact of jaundice-induced elevated red blood cell distribution width on survival outcomes in pancreatic cancer patients: a retrospective cohort study. Last author DOI 10.1186/s12876-026-04851-0↗
  5. A nomogram for predicting overall survival and cancer-specific survival in postoperative pancreatic cancer patients based on the SEER database. Co-author DOI 10.1016/j.asjsur.2024.07.305↗
  6. High expression ITGA2 affects the expression of MET, PD-L1, CD4 and CD8 with the immune microenvironment in pancreatic cancer patients. Co-author DOI 10.3389/fimmu.2023.1209367↗
  7. Body mass index, C-reactive protein, and pancreatic cancer: A Mendelian randomization analysis to investigate causal pathways. First author DOI 10.3389/fonc.2023.1042567↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rong Tang · 3 shared papers, 2026 · strength 0.72
  2. Xianjun Yu · 3 shared papers, 2026 · strength 0.72
  3. Haoyu Wang · 2 shared papers, 2026 · strength 0.54
  4. Yunbo Tan · 2 shared papers, 2023–2026 · strength 0.49
  5. Jiaoshun Chen · 2 shared papers, 2026 · strength 0.48
  6. Chen Chen · 2 shared papers, 2026 · strength 0.48
  7. Yiming Chen · 2 shared papers, 2023–2024 · strength 0.48
  8. Qiong Du · 2 shared papers, 2026 · strength 0.46
  9. Si Shi · 2 shared papers, 2026 · strength 0.46
  10. Zhiyang Li · 2 shared papers, 2023 · strength 0.39
  11. Jianhua Mao · 1 shared paper, 2024 · strength 0.31
  12. S. Y. Shi · 1 shared paper, 2026 · strength 0.26
  13. Miaoyan Wei · 1 shared paper, 2026 · strength 0.26
  14. Yingna Liao · 1 shared paper, 2026 · strength 0.26
  15. Junyi Xu · 1 shared paper, 2026 · strength 0.26
  16. Xiao-Yu Yin · 1 shared paper, 2026 · strength 0.24
  17. Chenghao Shao · 1 shared paper, 2026 · strength 0.24
  18. Jin Xu · 1 shared paper, 2026 · strength 0.23
  19. Zeyin Rong · 1 shared paper, 2026 · strength 0.23
  20. Hongyang He · 1 shared paper, 2023 · strength 0.22
  21. Xiaoxi Li · 1 shared paper, 2023 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.